0.67
+0.0699(+11.64%)
Currency In USD
| Previous Close | 0.6 |
| Open | 0.62 |
| Day High | 0.68 |
| Day Low | 0.61 |
| 52-Week High | 5.39 |
| 52-Week Low | 0.39 |
| Volume | 6.28M |
| Average Volume | 4.44M |
| Market Cap | 103.36M |
| PE | -0.51 |
| EPS | -1.31 |
| Moving Average 50 Days | 1.08 |
| Moving Average 200 Days | 2.3 |
| Change | 0.07 |
If you invested $1000 in Tenaya Therapeutics, Inc. (TNYA) since IPO date, it would be worth $43.66 as of March 14, 2025 at a share price of $0.67. Whereas If you bought $1000 worth of Tenaya Therapeutics, Inc. (TNYA) shares 3 years ago, it would be worth $62.29 as of March 14, 2025 at a share price of $0.67.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tenaya Therapeutics Announces Pricing of Public Offering
GlobeNewswire Inc.
Mar 04, 2025 4:19 AM GMT
SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underly
Tenaya Therapeutics Announces Proposed Public Offering
GlobeNewswire Inc.
Mar 03, 2025 9:10 PM GMT
SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underly
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
GlobeNewswire Inc.
Mar 03, 2025 1:00 PM GMT
SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underly